Member Info for Mafuta

Even more interesting to me would be ... how much a big pharmaceutical would cough up for our share of 737 should they take Sierra over?

I cannot understand why cannot people cannot understand that our products ARE NOT antivirals ... I despair sometimes ... It's like comparing antibiotics with diuretics ... Just taking the p!ss really ... Or is it a diversionary tactic?

Hi Eumac12 well done with your investment and welcome ... you will be rewarded for your patience

Glen ... I also have a feeling of deja vu on the current price movements .. been there got the tee shirt etc.

This little piggy went to market ... oink oink .... This little piggy is waiting for when I can go wee wee wee all the way home

Yep all the city piglets are gorging themselves ... And they know the main course is being cooked now and will be served in due time ... oink oink ... Keep you hand on your happenny

Potnak ... I believe Peel Hunt is a great broker ;0)

I have a strong suspicion that the next RNS we get may well be a TR1

The amount of traffic on the BB this morning plus the wild price swings shows me someone big is accumulating ... an excellent opportunity to top up if you can ... Sell at your peril ... sorry you're not getting any of mine ... Love hugs and kisses etc Mafuta

And of course there's the old adage: opinions are like @rseholes ... we all have them

I don't think PH are on board to market SAR more like to broker a deal

Emphasis on "a variety of diseases" ... Best thing since sliced bread and penicillin

Ore likely they are reminding us of this:

Tyk2 is widely involved in the immune and inflammatory response at multiple events; therefore, Tyk2 is likely to be a suitable target for treating patients with autoimmune and/or chronic inflammatory diseases. Clinical trials of Tyk2 inhibitors have shown higher response rates and improved tolerability in the treatment of patients with psoriasis and inflammatory bowel diseases. Taken together, Tyk2 inhibition has great potential for clinical application in the management of a variety of diseases.

Don't panic Mr Mainwaring don't panic

https://twitter.com/Sareumplc/status/1460249326425448454?t=E3-cSvJnREwDsM_d4oZ1LQ&s=19

An eloquence of verbosity?

Danny perhaps there's a gag order in place?

SAN MATEO, Calif.--(BUSINESS WIRE)-- Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer, today announced the company will participate in the 2021 Jefferies London Healthcare Conference. Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra, will provide an overview of the company in a presentation that will be available on demand beginning at 8:00 am GMT (3:00 am ET) on Thursday, November 18, 2021, to conference attendees.

Will be interesting to see what their presentation had to say about SAR737

... --- ...

"Data that we have generated on these new co-crystal forms in the past six months has shown improvements over the marketed form that justifies filing this new application." That's positive news indeed

Or to say even